Cresco Labs Inc. (CRLBF) — Earnings Call Analysis & IR Page

Cresco Labs Inc is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $271.1M market cap.

Most recent earnings call: Q1 FY26 on May 8, 2026.

21 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.80

investors.crescolabs.com/overview/default.aspx

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 21 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CRLBF.

$ curl https://api.spokenalpha.com/v1/companies/CRLBF

Get an API key API docs

FAQ

Frequently asked about CRLBF

Where can I find Cresco Labs Inc.'s (CRLBF) earnings call transcripts?

Spoken Alpha indexes CRLBF's earnings call transcripts at https://spokenalpha.com/companies/CRLBF. Each call links to attributed speakers and parsed analyst Q&A. Cresco Labs Inc.'s own investor relations page is at https://investors.crescolabs.com/overview/default.aspx.

When was Cresco Labs Inc.'s most recent earnings call?

Cresco Labs Inc. (CRLBF) held its most recent earnings call on 2026-05-08, covering fiscal Q1 2026.

What sector is CRLBF in?

Cresco Labs Inc. (CRLBF) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

Overview